LMF237

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LMF237, covering 2015-02-23 to 2015-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy [Phase 3]

See pricing